EARNEST Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $139M | Buy |
886,634
+1,344
| +0.2% | +$201K | 0.5% | 78 |
|
|
2026
Q1 | $135M | Sell |
885,290
-36,106
| -4% | -$5.53M | 0.56% | 63 |
|
|
2025
Q4 | $127M | Buy |
921,396
+81,370
| +10% | +$10.7M | 0.54% | 73 |
|
|
2025
Q3 | $108M | Sell |
840,026
-10,181
| -1% | -$1.24M | 0.47% | 83 |
|
|
2025
Q2 | $103M | Buy |
850,207
+25,836
| +3% | +$2.91M | 0.46% | 79 |
|
|
2025
Q1 | $91.9M | Buy |
824,371
+28,460
| +4% | +$3.03M | 0.44% | 90 |
|
|
2024
Q4 | $77.5M | Sell |
795,911
-13,236
| -2% | -$1.41M | 0.35% | 113 |
|
|
2024
Q3 | $93.1M | Sell |
809,147
-140
| -0% | -$15.9K | 0.41% | 98 |
|
|
2024
Q2 | $86.2M | Sell |
809,287
-26,264
| -3% | -$2.64M | 0.4% | 100 |
|
|
2024
Q1 | $80.8M | Buy |
835,551
+21,535
| +3% | +$2.21M | 0.37% | 103 |
|
|
2023
Q4 | $82.2M | Sell |
814,016
-1,822
| -0.2% | -$176K | 0.41% | 99 |
|
|
2023
Q3 | $83.1M | Sell |
815,838
-24,170
| -3% | -$2.45M | 0.48% | 88 |
|
|
2023
Q2 | $84.8M | Sell |
840,008
-10,754
| -1% | -$1.08M | 0.47% | 84 |
|
|
2023
Q1 | $78.3M | Sell |
850,762
-6,315
| -0.7% | -$552K | 0.45% | 97 |
|
|
2022
Q4 | $77.8M | Sell |
857,077
-14,641
| -2% | -$1.23M | 0.48% | 92 |
|
|
2022
Q3 | $66.3M | Buy |
871,718
+4,784
| +0.6% | +$397K | 0.45% | 96 |
|
|
2022
Q2 | $73.3M | Sell |
866,934
-26,592
| -3% | -$2.33M | 0.49% | 87 |
|
|
2022
Q1 | $78.4M | Sell |
893,526
-11,292
| -1% | -$978K | 0.46% | 90 |
|
|
2021
Q4 | $79.1M | Sell |
904,818
-37,394
| -4% | -$3.1M | 0.46% | 85 |
|
|
2021
Q3 | $77.1M | Sell |
942,212
-53,037
| -5% | -$4.77M | 0.47% | 85 |
|
|
2021
Q2 | $90.8M | Sell |
995,249
-77,132
| -7% | -$6.87M | 0.53% | 77 |
|
|
2021
Q1 | $91.7M | Buy |
1,072,381
+79,658
| +8% | +$7.15M | 0.55% | 71 |
|
|
2020
Q4 | $93.7M | Buy |
992,723
+20,661
| +2% | +$1.81M | 0.65% | 66 |
|
|
2020
Q3 | $84.5M | Sell |
972,062
-18,518
| -2% | -$1.6M | 0.73% | 53 |
|
|
2020
Q2 | $86.5M | Sell |
990,580
-342,241
| -26% | -$29.5M | 0.82% | 45 |
|
|
2020
Q1 | $110M | Sell |
1,332,821
-569,158
| -30% | -$50.8M | 1.24% | 18 |
|
|
2019
Q4 | $180M | Sell |
1,901,979
-38,288
| -2% | -$3.44M | 1.42% | 7 |
|
|
2019
Q3 | $169M | Buy |
1,940,267
+11,281
| +0.6% | +$1.01M | 1.52% | 8 |
|
|
2019
Q2 | $176M | Sell |
1,928,986
-246,689
| -11% | -$20.9M | 1.59% | 6 |
|
|
2019
Q1 | $187M | Buy |
2,175,675
+28,205
| +1% | +$2.26M | 1.79% | 3 |
|
|
2018
Q4 | $165M | Sell |
2,147,470
-29,796
| -1% | -$2.32M | 1.8% | 2 |
|
|
2018
Q3 | $168M | Sell |
2,177,266
-25,439
| -1% | -$1.88M | 1.51% | 5 |
|
|
2018
Q2 | $149M | Buy |
2,202,705
+3,684
| +0.2% | +$254K | 1.39% | 9 |
|
|
2018
Q1 | $159M | Sell |
2,199,021
-30,510
| -1% | -$2.32M | 1.51% | 9 |
|
|
2017
Q4 | $168M | Sell |
2,229,531
-9,463
| -0.4% | -$714K | 1.61% | 9 |
|
|
2017
Q3 | $172M | Sell |
2,238,994
-48,871
| -2% | -$3.69M | 1.72% | 7 |
|
|
2017
Q2 | $171M | Sell |
2,287,865
-24,876
| -1% | -$1.76M | 1.8% | 7 |
|
|
2017
Q1 | $154M | Sell |
2,312,741
-11,322
| -0.5% | -$754K | 1.64% | 10 |
|
|
2016
Q4 | $152M | Buy |
2,324,063
+322,585
| +16% | +$20.9M | 1.66% | 6 |
|
|
2016
Q3 | $142M | Sell |
2,001,478
-83,543
| -4% | -$6.09M | 1.49% | 8 |
|
|
2016
Q2 | $154M | Sell |
2,085,021
-274,541
| -12% | -$19M | 1.67% | 8 |
|
|
2016
Q1 | $153M | Sell |
2,359,562
-58,818
| -2% | -$4M | 1.6% | 9 |
|
|
2015
Q4 | $186M | Sell |
2,418,380
-73,943
| -3% | -$5.87M | 1.9% | 7 |
|
|
2015
Q3 | $205M | Buy |
2,492,323
+10,660
| +0.4% | +$949K | 2.02% | 7 |
|
|
2015
Q2 | $219M | Buy |
2,481,663
+64,968
| +3% | +$5.96M | 1.91% | 7 |
|
|
2015
Q1 | $214M | Sell |
2,416,695
-99,403
| -4% | -$8.82M | 1.84% | 6 |
|
|
2014
Q4 | $209M | Buy |
2,516,098
+52,570
| +2% | +$4.36M | 1.71% | 8 |
|
|
2014
Q3 | $208M | Sell |
2,463,528
-144,141
| -6% | -$11.7M | 1.74% | 6 |
|
|
2014
Q2 | $212M | Sell |
2,607,669
-38,317
| -1% | -$3.01M | 1.68% | 6 |
|
|
2014
Q1 | $202M | Buy |
2,645,986
+76,554
| +3% | +$5.58M | 1.62% | 6 |
|
|
2013
Q4 | $185M | Buy |
+2,569,432
| New | +$179M | 1.48% | 10 |
|
Other funds holding NVS
EARNEST Partners's NVS Position: Q2 2026 in Review
EARNEST Partners increased its Novartis (NVS) stake by 0.15% in Q2 2026, buying an estimated $201K and bringing the position to 886,634 shares worth $139M. The position accounts for 0.5% of the portfolio, ranked #78.
EARNEST Partners first reported a position in NVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $219M in Q2 2015. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- EARNEST Partners held 886,634 shares of Novartis worth $139M as of Q2 2026.
- EARNEST Partners bought 1,344 Novartis shares in Q2 2026, an estimated $201K.
- Novartis made up 0.5% of EARNEST Partners's portfolio in Q2 2026, its #78 holding.
- EARNEST Partners first reported a position in Novartis in Q4 2013 and has held it in 51 quarters since.
- EARNEST Partners's Novartis position peaked at $219M in Q2 2015.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.